Scientists Are Developing a First-Of-Its-Kind Pill To Help Dogs Live Longer

For many dog owners, one of the hardest realities is that their pets’ lives are much shorter than their own. Now, researchers are working on a potential breakthrough that could extend those years.

A US biotech company, Loyal, is developing what could become the first approved drug designed specifically to extend the lifespan of dogs.

What is the drug?

The treatment, known as LOY-002, is aimed at older dogs — typically those over the age of 10 and above a certain weight.

Rather than treating a single disease, the drug focuses on slowing the biological processes of ageing. The goal is not only to help dogs live longer, but to maintain their health and mobility during their later years.

How it works

The science behind the drug is based on “caloric restriction mimicry” — a concept suggesting that reducing calorie intake can positively affect how cells function and may extend lifespan.

LOY-002 attempts to replicate these effects without requiring strict diets, targeting metabolic pathways linked to ageing and delaying the onset of age-related conditions.

Progress so far

The drug is still under development but has reached an important milestone.

In 2026, the U.S. Food and Drug Administration accepted a key safety section of its application. Trials involving hundreds of dogs are already underway to evaluate both safety and effectiveness.

A final stage of regulatory review is still required before the drug can reach the market.

A shift in veterinary medicine

If approved, LOY-002 would be the first drug of its kind — not just for dogs, but for any species.

Experts say it could represent a major shift in how ageing is treated, focusing on prevention rather than reacting to illness after it appears.

For millions of families, dogs are more than pets — they are companions woven into everyday life. The idea of extending their healthy years is not just scientific progress, but an emotional one. Even a modest increase in lifespan could mean more shared moments, stronger bonds, and a better quality of life during a dog’s final years.